ArticleClinical pharmacology and therapeutics2011

In vivo CYP3A activity is significantly lower in cyclosporine-treated as compared with tacrolimus-treated renal allograft recipients.

H de Jonge et al.PubMed ↗Publisher ↗

No numbers read from the abstract.